
Primary care, reimbursement, and the path to type 2 diabetes remission
Wayne Dysinger, MD, MPH, DipABLM, FACLM, chief medical officer, Blue Zones Health
“The primary care setting allows you to start having those conversations very early on, and that’s the best time to reverse it.”
— Dr. Dysinger
How primary care and payment models can support lifestyle medicine at scale
Primary care plays a pivotal role in identifying and addressing type 2 diabetes long before complications develop. In this expert interview, Dr. Wayne Dysinger explains how early metabolic changes often precede a formal diagnosis by years, creating a critical window for intervention. By recognizing these early signals, primary care clinicians can begin therapeutic lifestyle interventions sooner, supporting treatment and, when used intensively, often enabling remission.
Dr. Dysinger also examines how current reimbursement structures influence care delivery. Traditional fee-for-service models tend to reward volume rather than health outcomes, making it difficult for clinicians to prioritize long-term disease reversal. He contrasts this with capitated and value-aligned approaches that incentivize keeping patients healthy over time. In these models, clinicians are better positioned to use tools such as lifestyle prescriptions, shared medical appointments, and coordinated care with dietitians, health coaches, and other healthcare team members.
Looking ahead, Dr. Dysinger emphasizes the need to equip primary care clinicians with the resources required to deliver lifestyle medicine effectively. From team-based care and digital tools to ongoing patient engagement beyond the clinic visit, these supports allow clinicians to focus on health restoration rather than disease progression. Together, thoughtful reimbursement design and lifestyle medicine–informed primary care can create a system that benefits patients, clinicians, employers, and communities alike.


More expert interviews
Eduardo J. Sanchez, MD, MPH, FAHA, chief medical officer for prevention, American Heart Association
Strategy for diabetes remission
Ed J. Stein, PharmD, MPH, DipACLM, consulting pharmacist, Modern Health Goals
The pharmacist’s role in remission
Josie Bidwell, DNP, RN, FNP-C, DipACLM, FACLM, professor & clinical director, Department of Preventive Director, Office of Well-being, University of Mississippi Medical Center
Rural health solutions
Mahima Gulati, MD, FACE, MSc, DipABLM, FACLM, board certified endocrinologist, UConn Health
The science of remission
Michelle McMacken, MD, FACP, DipABLM, executive director, Nutrition and Lifestyle Medicine, NYC Health + Hospitals
Scaling lifestyle medicine








